Phosphoric Acid

Phosphoric Acid

SCHEMBL198742

CCCCC(C)CC.CCCCC(C)CC.O=P(O)(O)O

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
FDPS P14324 7/20 0.54
LAP3 P28838 2/20 0.43
TRPM8 Q7Z2W7 2/20 0.41
CA2 P00918 1/20 0.41
MAPK1 P28482 1/20 0.41
SMPD1 P17405 3/20 0.41
ACE2 Q9BYF1 1/20 0.41
CYP3A4 P08684 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL28487358 1.00 FDPS (0.54) FDPSLAP3TRPM8CA2MAPK1
Phosphoric Acid SCHEMBL9193113 1.00 FDPS (0.54) FDPSLAP3TRPM8CA2MAPK1
Phosphoric Acid SCHEMBL10781154 1.00 FDPS (0.54) FDPSLAP3TRPM8CA2MAPK1
Phosphoric Acid SCHEMBL9195623 1.00 FDPS (0.54) FDPSLAP3TRPM8CA2MAPK1
Phosphoric Acid SCHEMBL6446005 1.00 FDPS (0.54) FDPSLAP3TRPM8CA2MAPK1
Phosphoric Acid SCHEMBL29226708 0.98 FDPS (0.52) FDPSLAP3TRPM8CA2MAPK1
Benzene SCHEMBL1133672 0.94 FDPS (0.48) FDPSLAP3TRPM8CA2MAPK1
SCHEMBL9231486 0.86 FDPS (0.43) FDPSLAP3CA2MAPK1ACE2
SCHEMBL598266 0.86 FDPS (0.43) FDPSLAP3CA2MAPK1ACE2
SCHEMBL4916295 0.86 FDPS (0.43) FDPSLAP3CA2MAPK1ACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260138879-A1 MODIFIED LAYERED DOUBLE HYDROXIDE (LDH), PARTICLES COMPRISING SAID LDH, AND METHOD FOR PRODUCING SAID LDH KISUMA CHEMICALS B V (NL) 2026-05-21 US claimed
EP-4605346-A1 MODIFIED LAYERED DOUBLE HYDROXIDE (LDH), PARTICLES COMPRISING SAID LDH, AND METHOD FOR PRODUCING SAID LDH Kisuma Chemicals B.V. (NL) 2025-08-27 EP claimed
WO-2024146843-A1 METHOD FOR PREPARING A NEODYMIUM ALKYL PHOSPHATE SOLUTION UMICORE SPECIALTY MATERIALS BRUGGE NV (BE) 2024-07-11 WO claimed
WO-2024085755-A1 MODIFIED LAYERED DOUBLE HYDROXIDE (LDH), PARTICLES COMPRISING SAID LDH, AND METHOD FOR PRODUCING SAID LDH KISUMA CHEMICALS B.V. (NL) 2024-04-25 WO claimed
EP-4320076-A1 PROCESS FOR PRODUCING HIGH PURITY ALUMINIUM MATERIALS Hipura Pty Ltd (AU) 2024-02-14 EP claimed
WO-2023279151-A1 \"PROCESS FOR PRODUCING HIGH PURITY ALUMINIUM MATERIALS\ HiPurA Pty Ltd (AU) 2023-01-12 WO claimed
EP-2618903-B1 PROCESS FOR RECOVERING AND RECYCLING AN ACID CATALYST EASTMAN CHEM CO (US) 2016-01-27 EP claimed
US-9228248-B2 Method of recovering rare-earth elements NIPPON LIGHT METAL COMPANY, LTD. (JP) 2016-01-05 US claimed
US-9068249-B2 Rare earth element recovery method NIPPON LIGHT METAL COMPANY, LTD. (JP) 2015-06-30 US claimed
EP-2831040-A1 PROCESS FOR RECOVERING AND RECYCLING AN ACID CATALYST Eastman Chemical Company (US) 2015-02-04 EP claimed
US-8354085-B1 Actinide and lanthanide separation process (ALSEP) U.S. DEPARTMENT OF ENERGY (US) 2013-01-15 US claimed
US-20120215027-A1 PROCESS FOR RECOVERING AND RECYCLING AN ACID CATALYST EASTMAN CHEMICAL COMPANY (US) 2012-08-23 US claimed
US-20120078010-A1 PROCESS FOR RECOVERING AND RECYCLING AN ACID CATALYST EASTMAN CHEMICAL COMPANY (US) 2012-03-29 US claimed
WO-2012040007-A2 PROCESS FOR RECOVERING AND RECYCLING AN ACID CATALYST EASTMAN CHEMICAL COMPANY (US) 2012-03-29 WO claimed
US-8088499-B1 Optoelectronic device with nanoparticle embedded hole injection/transport layer AGILTRON, INC. (US) 2012-01-03 US claimed
US-20100078598-A1 CONDUCTIVE POLYMER COMPOSITION FOR RADIOGRAPHIC IMAGING ELPANI CO., LTD. (KR) 2010-04-01 US claimed
US-6863592-B2 Chemical/mechanical polishing slurry and chemical mechanical polishing method using the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2005-03-08 US claimed
US-20040033764-A1 Chemical/mechanical polishing slurry and chemical mechanical polishing method using the same SAMSUNG ELECTRONICS CO., LTD. 2004-02-19 US claimed
US-6540935-B2 Chemical/mechanical polishing slurry, and chemical mechanical polishing process and shallow trench isolation process employing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2003-04-01 US claimed
US-4649107-A Phenylethanolamine N-methyltransferase based radioenzymatic assay for norephinephrine ELI LILLY AND COMPANY (US) 1987-03-10 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260138879-A1 MODIFIED LAYERED DOUBLE HYDROXIDE (LDH), PARTICLES COMPRISING SAID LDH, AND METHOD FOR PRODUCING SAID LDH LDHA, LDHB, ME2 FDPS 4476/4885LAP3 2224/4885TRPM8 4116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.